Drugs with Dosage: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
✉ Email this page to a colleague
Drugs with Dosage: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | Dosage |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | AMPHETAMINE | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 209253-001 | Jun 22, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | ||||
Actavis Labs Fl Inc | AMPHETAMINE | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 209253-002 | Jun 22, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | ||||
Actavis Labs Fl Inc | AMPHETAMINE | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 209253-003 | Jun 22, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | ||||
Actavis Labs Fl Inc | AMPHETAMINE | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 209253-004 | Jun 22, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration | >Dosage |